Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study
Cazzaniga, M. E., Torri, V., Villa, F., Giuntini, N., Riva, F., Zeppellini, A., Cortinovis, D., Bidoli, P.
Published in International Journal of Breast Cancer (01.01.2014)
Published in International Journal of Breast Cancer (01.01.2014)
Get full text
Journal Article
248 Long Term Treatment with an All-oral Metronomic Schedule of Vinorelbine (VRL) and Capecitabine (CAPE) in Metastatic Breast Cancer (BC) Patients (pts). Preliminary Results of Toxicity and Efficacy of the VICTOR-2 Study
Cazzaniga, M.E, Villa, F, Torri, V, Giuntini, N, Cortinovis, D
Published in European journal of cancer (1990) (01.03.2012)
Published in European journal of cancer (1990) (01.03.2012)
Get full text
Journal Article
6131 POSTER Evaluation of BRAF Mutational Status in Wild Type (WT) KRAS Metastatic Colon-Rectal Cancer (MCRC) Patients (pts) Treated With Cetuximab (C) – a Single Institution Experience
Cazzaniqa, M.E, Baronchelli, S, Bovo, G, Pellizzoni, D, Crosti, F, Giuntini, N, Villa, F, Cortinovis, D, Bidoli, P
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Abstract P6-11-10: Full-Oral, Metronomic Schedule of Vinorelbine (VNB) and Capecitabine (CAPE) in Locally Advanced or Metastatic Breast Cancer (BC) Patients (Pts): A Single Institution, Dose-Finding Study
Cazzaniga, ME, Torri, V, Villa, F, Giuntini, N, Zeppelini, A, Cortinovis, D, Bidoli, P.
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Get full text
Journal Article